Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Botulinum toxin type A by Microgen for Migraine: Likelihood of Approval
Botulinum toxin type A is under clinical development by Microgen and currently in Phase III for Migraine. According to GlobalData,...